---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-022954"
form_type: "8-K"
ticker: "NORD"
cik: "0001011060"
company_name: "Nordicus Partners Corp"
filed_at: "2025-08-11T23:59:59+00:00"
generated_at: "2026-05-17T15:06:33.030121+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "low"
source: SEC EDGAR
---

# Nordicus Partners furnishes independent valuations for Orocidin and Bio-Convert subsidiaries

## Summary
- Stanton Park Advisors LLC prepared valuation reports for Orocidin's QR-01 and Bio-Convert's QR-02 as of June 30, 2025.
- The valuations are intended for Board evaluation of fair market value and should not be relied upon for other purposes.
- No specific valuation figures are disclosed in the filing; exhibits are placeholders only.

## SEC filing metadata
- accession: 0001641172-25-022954
- form_type: 8-K
- ticker: NORD
- cik: 0001011060
- company_name: Nordicus Partners Corp
- filed_at: 2025-08-11T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1011060/000164117225022954/0001641172-25-022954-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1011060/000164117225022954/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-022954
- JSON: https://secwatch.observer/filing/0001641172-25-022954.json
- Plain text: https://secwatch.observer/filing/0001641172-25-022954.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.